Beacon Hill Medical Pharmacy Recalls Cyanocobalamin Injections Due to Sterility Concerns
Beacon Hill Medical Pharmacy is recalling compounded cyanocobalamin injections because FDA inspections raised concerns about sterility assurance and quality control.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls involving significant quality control failures like sterility assurance in injectable products are categorized as Severe.
Plain-English summary
Beacon Hill Medical Pharmacy, P.C. is recalling all presentations of CYANOCOBALAMIN 1000 MCG/ML INJ SOLN, compounded for intravenous and subcutaneous use. The recall was initiated following FDA inspectional findings that identified concerns associated with quality control procedures impacting sterility assurance.
The affected product is a sterile, prescription-only compounded solution distributed nationwide in the United States. The recall covers specific batches identified by the following codes: 01092013@12, 02132013@17, 03122013@21, 04122013@33, 05132013@17, 05282013@26, 06052013@33, 06252013@4, 06272013@2, and 07152013@41.
Patients who have received this medication should consult their healthcare provider for guidance. The source text does not report any specific illnesses or injuries associated with the use of these products.
The recalled product
- Product
- CYANOCOBALAMIN 1000 MCG/ML INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI
- Manufacturer
- Beacon Hill Medical Pharmacy, P.C.
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- 01092013@12
- 02132013@17
- 03122013@21
- 04122013@33
- 05132013@17 05282013@26
- 06052013@33
- 06252013@4
- 06272013@2
- 07152013@41
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 86 recalled by Beacon Hill Medical Pharmacy, P.C. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Beacon Hill Medical Pharmacy, P.C.
See all →- SevereBeacon Hill Medical Pharmacy Recalls B-12 Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- HighBeacon Hill Medical Pharmacy Recalls Sermorelin Acetate Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereBeacon Hill Medical Pharmacy Recalls Potassium Chloride Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereBeacon Hill Medical Pharmacy Recalls Alprostadil Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereBeacon Hill Medical Pharmacy Recalls Multitrace-5 Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereCyanocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- HighCyanocobalamin Injection Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- SevereCyanocobalamin Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- SevereCyanocobalamin and B-Complex Injection Recalled for Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereKey Pharmacy Recalls Cyanocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereRed Mountain Compounding Recalls S-Cyanocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-11-13